Judy Foreman

Nationally Sindicated Fitness, Health, and Medicine Columnist

  • HOME
  • Books
  • BIO
  • BLOG
  • COLUMNS
  • Q&A
  • PRESS
  • CONTACT

Column Search

Column Categories

  • General Medicine
  • Women's issues
    • Breast Cancer
    • Hormone replacement
  • Cancer
  • Alternative Medicine
  • Nutrition
  • Exercise/Fitness
  • Heart Disease
  • Aging
  • Pain
  • Dental
  • Allergies
  • Mental Health
    • Depression
    • Alcohol
    • Loneliness/Loss
    • Sleep Problems
    • Anxiety

Herbal prostate drug goes mainstream

October 4, 1999 by Judy Foreman

The gradual enlargement of the prostate gland with age is “the most common benign disease of mankind,” says Dr. Kevin R. Loughlin, director of urologic research at Brigham and Women’s Hospital in Boston.

And while many men now try to treat it with herbal remedies, many still prefer the traditional therapies, for which there are considerably more data. Some combine both approaches.

Although benign prostatic hyperplasia, or BPH, does not lead to prostate cancer, both BPH and prostate cancer are hormone-driven. Testosterone drives prostate cancer. A hormone called DHT, or dihydrotestosterone, made from testosterone, drives BPH.

Several types of prescription drugs are used to treat BPH. For mild cases, doctors often use “alpha blocking” drugs such as Hytrin, Cardura or Flomax that improve urination by relaxing the muscles in the urethra, the tube through which urine flows. Hytrin and Cardura are also used to treat high blood pressure, and in some men being treated for prostate problems, may cause a sharp drop in pressure.

For men with more advanced BPH, a drug called Proscar, which blocks the conversion of testosterone to dihydrotestosterone, can help. In theory, because Proscar blocks DHT but not testosterone itself, libido and potency are not affected, but in practice, some men taking Proscar do encounter these side effects.

Proscar can also muddy the results of the PSA, or prostate specific antigen, test used to detect prostate cancer. (The PSA test is imperfect to begin with: a high score may indicate cancer, BPH or even just a prostate infection; conversely, a man can have cancer, BPH or an infection with a normal score.)

After several months on Proscar, PSA levels often drop by half. In general, a normal PSA score is 0 to 4 (nanograms per milliliter); but age counts, so this is often refined so that normal for a man in his 40s is 0 to 2.5; in his 50s, 0 to 3.5, in his 60s, 0 to 4.5 and in his 70s, 0 to 6.5.

If a man takes Proscar and his PSA score drops, his doctor should mentally double the score so as not to underestimate the risk of prostate cancer, Loughlin says.

If drugs fail, four surgical options are available:

  • TURP, or transurethral resection of the prostate. With the patient under regional or general anesthesia, the surgeon inserts a cystoscope (viewing instrument) into the urethra. A wire-like scoop at the tip is then pushed through into surrounding tissue. This takes about an hour and can cause bleeding. After healing, a man can have normal sex, including orgasm, but usually has retrograde ejaculation, in which sperm flows backward into his bladder, which is not harmful. A TURP has excellent longterm efficacy: 7 years later, 80 to 90 percent of men still have relief from BPH.

  • Laser TURP. This is like a regular TURP except that laser energy, delivered through a fiber optic tube, is used to destroy prostate tissue. The laser heats tissue, causing it to contract over several weeks. The surgery takes 20 minutes and causes less bleeding than a standard TURP and less likelihood of retrograde ejaculation. But longterm efficacy has not been proved.

  • TUNA, or transurethral needle ablation. This is like a laser TURP except that radiofrequency energy is used instead of lasers. And unlike a TURP, the surgeon does not operate through a viewing tube, so the procedure is “blind.” Longterm efficacy has not been proved.

  • TUMT, or transurethral microwave therapy. This is like TUNA, except that microwave energy is used to destroy prostate tissue. Longterm efficacy has not been proved.

Cell transplants, drugs tested for spinal injuries

September 27, 1999 by Judy Foreman

The experiments creating the biggest buzz among spinal cord researchers are those involving fetal cell, stem cell or embryonic stem cell transplants. So far, most of the research is in animals, though some studies are beginning in people.

In all three methods, the idea is essentially the same: To implant in the damaged spinal cord immature cells that can be nudged to grow into many, perhaps all, of the thousands of different types of nerve cells in the body. The immature cells can also be genetically engineered to produce large quantities of the chemical messengers believed to stimulate new nerve growth.

Ideally, the cells would be transplanted into a patient within a week or two of injury, but the ultimate goal is to use them months or even years later to stimulate nerve growth.

In embryonic stem cell transplantation, cells are taken from embryos at the 8- to 12 cell-stage, says Dr. John W. McDonald, director of the spinal cord injury program at Washington University in St. Louis. These cells, isolated for the first time only a year ago, then differentiate into every type of cell in the body, including spinal nerve cells.

In fetal cell transplants, tissue is taken from the spinal cords of aborted fetuses. Researchers at the University of Florida are already trying this method in a few patients to see if it yields new nerve growth.

At Cedars-Sinai Medical Center in Los Angeles, researchers are gearing up for a study in which they would take nerve stem cells from the brains of patients with spinal cord injuries, grow them in large numbers in the lab, and re-inject them to trigger new nerve growth. Once thought non-existent in adults and still tough to identify in the lab, neural stem cells – presumably left over from fetal development – have been shown to exist in the brain in the lining of spaces called ventricles, in the hippocampus, a memory center, and in the spinal cord.

If the basic cell transplant strategy works in humans – and researchers should know in two to five years – it could eclipse everything else now in testing.

Already, researchers have been able to insert into neural stem cells “marker” genes that show where the cells migrate after being injected into animals and what kinds of nerve cells they become, says Dr. Evan Snyder, a neuroscientist at Children’s Hospital in Boston.

In fact, preliminary research shows that if human neural stem cells are injected into mice three or four days after a spinal cord injury, the cells move to exactly where they’re needed and start replacing the cells that were damaged, Snyder notes.

At a neuroscience meeting next month, McDonald’s team will present data showing that embryonic stem cells can restore function by replacing cells lost after spinal cord injury in rats, even if they’re transplanted as long as nine days later.

A glimmer of hope

September 20, 1999 by Judy Foreman

Ten years ago scientists scoffed at the thought that a paralyzed person could walk again; today they’re counting on it.

Four years after being paralyzed from the neck down in a riding accident, Christopher Reeve is preparing to walk again, a feat long assumed to be impossible for any quadriplegic, even Superman.

As scientists work to develop drugs to minimize acute spinal cord damage and hunt for new ways to spur regeneration even long afterwards, Reeve is trying to “meet the scientists halfway. . .”

Speaking openly, often eloquently, by phone from his Bedford, New York home, despite his reliance on a respirator to breathe, Reeve believes that, ultimately, “recovery will go to the fittest.”

So every day, he has an electrical device attached to his muscles to stimulate contractions. “I have no loss of tone whatsoever,” he says, adding that his calf muscles “are the exact same size as when I was injured.”

To prevent osteoporosis, which can be caused by a lack of weight-bearing exercise, he is strapped to a “tilt table” and raised to a vertical position to force his weight onto his feet.

He also “walks” on a treadmill — his weight suspended in a harness, his feet propelled by the moving belt. The theory is that spinal nerves can be retrained to make the legs move in a coordinated way, even though the messages that control voluntary leg movements can’t get from the brain down to the legs across the damaged area of the spinal cord.

Ten years ago, if anyone as badly injured as Reeve even dreamed of walking again, scientists would have scoffed. Reeve’s injury is not only high on his spinal cord, it’s “complete,” which means the nerve fibers are cut all the way across, not just partway, as in some cases.

Indeed, the dogma has long been that, while nerves in the arms and legs regenerate, those in the central nervous system do not — a grim fact of life for 10,000 Americans a year whose spinal cords are injured as a result of car crashes, sports accidents and violence, and for the quarter million more living with their injuries, most of whom with fewer resources than Reeve.

But thanks to an explosion of new research — some to be presented next month at a major neuroscience conference in Miami — that pessimism is cracking.

“It will be a long, arduous path, but I no longer think it’s impossible for people with severe, even high, spinal cord injuries, to walk again,” says Dr. Evan Snyder a neuroscientist at Children’s Hospital in Boston and one of the leaders in spinal cord regeneration research.

“There is tremendous new hope. The neat thing is that the central nervous system does have the capacity to regenerate — we just need to harness it. And we’re also getting better at using advances in electronics and surgery to maximize a person’s independence,” says Dr. John W. McDonald, director of the spinal cord injury program at Washington University in St. Louis.

Electronic devices can help paralyzed patients gain control over their bladders; a drug called NT-3 seems to help the bowel work on command; and early data suggest another drug called inosine helps healthy nerves grow toward the damaged area.

Surgeons can also do “tendon transfers” to restore limited movement to paralyzed muscles by hooking them to still-functioning tendons. Many primary care doctors don’t think to recommend this, McDonald says, but by re-jigging tendons so a patient can grasp things between the thumb and forefinger, a person may be able to feed himself.

Indeed, a half-dozen new therapies to repair damaged spinal cords, including cell transplants, are or soon will be in human trials, says Dr. Wise Young, a neuroscientist at Rutgers University in New Jersey. “The hope is that if we can get 10 to 15 therapies going in parallel, at least one of them will hit.”

None of the new approaches was “dreamt of 10 to 15 years ago,” adds Arlene Chiu, who runs the spinal cord injury program at the National Institute of Neurological Disorders and Stroke. “So on that basis, I’d say things are very promising,” even though, so far, most research is in animals, not people.

Still, the challenges are daunting, almost as if evolution had “decided” that a spinal cord injury was so devastating, it was not worth investing the resources it would take to heal it.

The spinal cord, which runs inside the backbone, is only as thick as a thumb, but it’s through this channel that the brain sends signals through descending nerves onward to muscles and organs and carries messages, such as pain signals, up through ascending, sensory nerves.

Deep in the center of the cord lie the nerve cell bodies called “gray matter;” branching out from these are tendrils called dendrites, which catch incoming electrical signals; also projecting out are filaments called axons through which nerves send outgoing signals.

Some axons are long, running the entire length of the cord. Because they are coated with a white insulating material called myelin, bundles of axons are called “white matter.” Both white and gray matter also contain supporting cells called glia, and oligodendrocytes, which make the myelin.

The organization of the cord means that below an injury, nerves (and the muscles and organs they control) don’t work well or at all, while above it they do. It also means that below certain injuries, a person can feel nothing — neither pain nor pleasure.

If you injure your cord in the neck region, you may not be able to breathe without a respirator because the nerves that control the diaphragm won’t work; if you injure your cord farther down, you may have control over breathing and arm movements, but not over your legs, bladder and bowel. If the cord is not severed all the way across, there may be some function below the injury because some nerves still work.

When the cord is injured, there is instant damage to the immediate area: the bony vertebrae crush axons, rendering them useless. But for days, weeks, even months later, the damage spreads up and down the cord.

Ruptured blood vessels no longer deliver oxygen, causing waves of cell death. Damaged cells pump out glutamate, which triggers a cascade of chemical events that is fatal to nerve cells, including the release of destructive oxygen molecules called free radicals.

The injured cord also pumps out chemical signals such as IN-1 that inhibit regeneration of nerves. Axons that survive the initial injury may also lose their myelin coating, without which they can’t transmit signals. Glial cells clump into scar tissue, making it even harder for nerves on both sides of an injury to hook up. And inflammation, including the influx of immune cells that destroy nerve cells, further fans the flames of destruction.

But in 1990, the picture began to brighten when Dr. Michael Bracken and his team from Yale University showed that a drug called methylprednisolone, injected in huge doses in the first eight hours after injury, prevented some of this damage by blocking free radicals.

“This was the first time anything had been shown to work in spinal cord injury,” says Bracken, a neurologist. To this day, methylprednisolone is the only drug approved to treat either acute or chronic spinal cord injury.

But other ways to treat the cord in the immediate aftermath of injury are in the pipeline, including a drug called an AMPA antagonist that blocks glutamate receptors, likely to be studied in humans soon, and another called interleukin-10 that blocks inflammation, at least in rats.

Cooling the body after injury also slows damage in rats, says Naomi Kleitman, a neuroscientist at the Miami Project to Cure Paralysis.

The implications are compelling. The more doctors can limit the immediate injury, the more they can focus on the really tough part: restoring nerve function in people whose spinal cords were injured months or years earlier.

It’s a tall order, but Christopher Reeve is ready: “I expect full recovery — up to and including walking.” SIDEBAR 1: Getting a lift from new devices, wheelchairs

The holy grail of spinal cord research is to restore some or all nerve function, but even in the most optimistic scenarios, that’s still five years away. In the meantime, however, new devices and better medical care can improve the quality of life for the estimated 230,000 Americans living with spinal cord injuries, and for many others with mobility disorders as well.

Two years ago, the US Food and Drug Administration approved an electronic signalling device that allows some quadriplegics — people whose arms and legs are paralyzed — to regain partial use of one hand. In January, the agency approved another electronic device that restores some control over bladder, bowel and penile function.

And three months ago, Johnson & Johnson began human testing of a fancy, $20,000 wheelchair that can operate on two wheels or four and can climb stairs, go up hills and maneuver over curbs.

To be sure, even with better devices, learning to live with a spinal injury is a task that takes time “and a lot of work,” says Michael Ferriter, 47, a carpenter who was injured in a work accident 20 years ago.

But with every new device and improvement in basic care, the lives of paralyzed people get a bit better, though the amount of care necessary — and the cost, estimated to be $1.4 million over the life of a spinal injury patient — are huge.

That’s because a spinal cord injury can affect every organ and body function below the level of injury: muscles, bones, skin, blood vessels, internal organs and breathing, notes Dr. Daniel Lyons,, medical director of the spinal cord injury program at Health South/New England Rehabilitation Hospital in Woburn.

Without skin sensation, for instance, a person can’t tell when he’s getting sore from sitting too long in one position. This can lead to pressure sores and ulcers, which can lead to infections. The solution here is low tech: having someone monitor the skin, helping the patient change position often, and developing better cushions for wheelchairs.

Blood clots are another challenge. Because a paralyzed person can’t move, blood can pool in the legs and form clots that travel to the lungs. One solution is to take a blood thinner such as Lovenox.

Heart arrhythmias are a problem, too. In a healthy person, signals from the parasympathetic nerves, which tend to slow down heart rate, are coordinated with signals from the sympathetic nerves, which tend to speed it up.

But in many people with spinal injuries, this balance is thrown off. The parasympathetic nerves remain intact because they branch off high on the spinal cord, while the sympathetic nerves, which branch off lower, are damaged. The result is that the heart beats erratically because slow-down messages are not coordinated with speed-up ones. The body can compensate but if it can’t, implantable pacemakers can help.

Breathing, even just coughing, can be another huge problem. The solution is often to use a respirator, which literally pushes air into the lungs, though rehabilitation specialists try to wean people with some remaining nerve function off respirators and teach them to strengthen muscles in the diaphragm and neck to assist with breathing.

Depression is also a threat. Though many patients regain significant quality of life, says Lyons, getting to that point is difficult. “Everyone does it differently,” he says. “Well-educated business executives are often very devastated early on, then do very well as time goes by,” he says.

“Younger people who don’t have a lot of plans for their lives sometimes do well early on, then have more difficulty later as they realize that things will be tough.”

Mobility is an obvious challenge, too. At UCLA and the Miami Project to Cure Paralysis, researchers are trying to retrain damaged spinal cords by suspending a patient over a moving treadmill.

In some patients, the legs move involuntarily, and even do so in a coordinated — left foot, right foot — manner. Researchers theorize that even below the level of injury, there may be a neural “pattern generator” and “memory” in the cord that — without messages from the brain — may make walking possible.

German researchers have demonstrated improvements in mobility by putting such patients on a treadmill, says Reggie Edgerton, a UCLA physiologist pioneering the method. But so far, no one with a “complete” cord injury (one that cuts across the entire cord) has been able to regain the ability to walk.

Of more immediate benefit to many is the Freehand device, made by the NeuroControl Corp., to regain use of a hand.

The Freehand system uses a sensing device taped to the skin on the shoulder. Wires from the sensor run to an external control box and from there to a transmitting coil taped to the chest. Just under that coil is a stimulating device that is implanted surgically under the skin.

Leads from the implanted device run down the arm to electrodes on the fingers and thumb. When the shoulder is moved, signals travel down to the hand. So far, about 150 people worldwide are using the device.

The VOCARE system, distributed by NeuroControl and made in England, is similar. In this case, the implantable part of the system is surgically placed under the skin on the abdomen, with electrodes on nerves to the bladder, bowel and in men, the penis. The transmitter coil is held or taped to the skin over the implant and the unit is controlled externally by the patient if he has sufficient hand control, or by a helper. The device, which allows patients to urinate, defecate or get an erection, is now used by 1,500 people worldwide, most of them in Europe.

Michael Ferriter, the carpenter injured in a work accident, welcomes the new options for treatment of injuries like his. But he also has hard-won advice: “Live healthy — mentally, physically and spiritually until there’s a cure. Don’t wait for it. Live it now. . .You’ve got to do it. That’s what life is about.”

Plaque can gum up the works in legs

September 13, 1999 by Judy Foreman

Dr. Zdan Korduba, an anesthesiologist at St. Luke’s-Roosevelt Hospital Center in New York, wound up having one toe amputated, losing months of work and feeling like a total chump for missing symptoms he’d have spotted right away in a patient.

Beginning five years ago, he says ruefully, he began noticing that his legs hurt after tennis: “I got tremendous cramps, but I put it off as being out of shape.” Before long, he found he “couldn’t walk the same distance as before. I kept denying this to myself. My diabetes was not the best controlled, either.”

Seven months ago, he couldn’t even walk two blocks from the garage to the hospital without tremendous pain in his right leg. “It hit me I was in trouble. . .If a patient had come to me with these symptoms, I would have diagnosed it as peripheral vascular disease. But on yourself, you’re the worst patient there is. It was denial.”

Like Korduba, an estimated 10 million Americans, many of them over 50, have peripheral vascular disease, or PVD – clogged arteries in the legs (and occasionally, the arms) that trigger numbness or intense pain (a kind of “heart attack” in the legs) during even minimal activity. Many, like Korduba, are in denial, chalking up their pain to age or arthritis.

In fact, so many people go undiagnosed and untreated that, beginning today for a week, a coalition of medical organizations is taking the unusual step of offering free screening and referrals for peripheral vascular disease at 500 hospitals across the country, including three in the Boston area. (See sidebar for locations.)

Peripheral vascular disease is caused by the same phenomenon that clogs coronary arteries and triggers chest pain – atherosclerosis, the build-up of cholesterol-filled plaques. Just as angina, or chest pain, is a sign the heart isn’t getting enough oxygen-rich blood, especially upon exertion, leg pain after a minimal amount of walking means leg muscles are starving for oxygen, too.

And since atherosclerosis is a body-wide process, clogged arteries in the legs are often a sign that those that supply the heart and brain may be dangerously narrowed as well, notes Dr. Cameron Akbari , a vascular surgeon at Beth Israel Deaconess Medical Center in Boston.

In fact, if you have peripheral vascular disease and heart disease, you have six times the risk of dying of a heart attack as someone who has heart disease alone, says Dr. Rodney Raabe , director of radiology at the Sacred Heart Medical Center in Spokane, Wash., and co-director of the screening program “Legs for Life.”

But PVD can be a life-wrecker in its own right, too. It not only severely impairs mobility but can lead to skin ulcers and gangrene and ultimately, may require the amputation of toes, feet or legs, especially in diabetics, who are at high risk of circulatory problems to begin with, says Dr. Max Rosen , an interventional radiologist at Beth Israel.

Now, if you’re a reasonably active sort whose legs feel crampy after you overdo the weekend jock thing, don’t panic. There’s a world of difference between legs that feel sore the morning after a strenuous workout and legs that cramp up after a short walk across the kitchen or down the block. “People with PVD can’t do half an hour on the treadmill,” says Rosen.

PVD is also different from (though sometimes confused with) the leg pain that occurs during sleep, or sciatica, pressure on a major nerve to the leg caused by a ruptured spinal disk.

 The hallmark of PVD is the pain’s utter predictability. It comes on after a set amount of walking – often only a few minutes – and goes away when you stop, then starts up again when you walk the same distance again.

Screening for PVD is easy – and painless. The doctor or nurse simply takes your blood pressure on your arms and on your lower legs and calculates what’s called the ABI, or ankle-brachial index. The pressure should be roughly the same. If it’s lower in the legs, it means blood flow to the legs may be compromised.

If the screening shows you have or are at risk for peripheral vascular disease, you’ll be referred for further testing. This includes more sophisticated blood pressure monitoring all up and down on the legs and a “Doppler” ultrasound test as well.

This non-invasive test shows how fast blood is moving through blood vessels; if it speeds up in one spot, it means the blood is rushing to get through a narrowed area. If there’s no flow at all, that’s obviously even bigger trouble.

For some people, doctors may also recommend an angiogram, in which they thread a small catheter through an artery in the groin, inject dye, and watch on an X-ray screen to see where blood vessels narrow dangerously.

If you’re diagnosed with mild peripheral vascular disease, the remedy, believe it or not, may be to walk through the pain to force collateral blood vessels to take up the slack and, over time, supply leg muscles with oxygen. People with PVD are often given aspirin, too, notes Dr. Mitchell Rivitz , a radiologist at Newton-Wellesley Hospital. Aspirin makes blood less likely to clot as it travels through narrowed areas of blood vessels.

If those remedies don’t help, doctors can perform balloon angioplasty just as they would for a clogged coronary artery. They insert a small balloon-tipped catheter into the artery under X-ray guidance, inflate the balloon and push apart the artery walls to let more blood flow through.

They may also insert a stent, a metal device that stays in the narrowed area to keep the vessel open, or perform bypass surgery, stitching a small segment of vein taken from elsewhere in the patient’s body to carry blood around the bottleneck in the artery. If the narrowing of the artery is caused by a clot, they may inject clot-busting drugs like t-PA.

Some doctors are also experimenting with injections into the legs of a gene for vascular endothelial growth factor, a protein that causes new blood vessels to grow in the area. They’re also working on using radiation along with stents to stop vessel narrowing.

When Dr. Korduba finally consulted a surgeon, he recommended walking through the pain. It worked, for a while. He kept playing tennis, too, “not well, but I was playing.”

Then, he says, he got a blister on his little toe “which I did not pay attention to.” The pain soon spread to his foot. Before long, his wife noticed a black spot right under the blistered toe. He went back to his surgeon, who admitted him to the hospital immediately.

He had angioplasty, which increased blood flow in his leg overall. But he still had a gangrenous, black spot – dead tissue – in his toe, so the next day, he had surgery to have the toe amputated so that it didn’t cause a life-threatening infection. To make sure the wound drained as it healed, doctors did not close the incision.

That meant staying home from work – it’s been two months so far – and having a nurse come twice a day to clean and pack the wound. “I’m Dr. Mom now,” says Korduba, who spends a lot of time helping his kids with their homework.

And he’s learned two things. “I have now become a kinder and gentler doctor. I’ve been practicing for 29 years, and you get a little jaded. You forget the patient is not just a patient but a human being. When you start looking at the ceiling from a stretcher, you become restless and agitated with any little delay. . . .I’ve certainly learned a lot being a patient.”

He’s also got new respect for how serious peripheral vascular disease can be and for the dangers of denying it. “That denial is the worst thing. This is a sneaky disease. When you get the symptoms, you’re in trouble.” He’s “not looking for glory” by telling his story, he adds. “This is not my finest moment.”

Risks for vascular disease

You are at higher than normal risk for peripheral vascular disease if you are over 50, male or a smoker. Other risk factors include high blood pressure, diabetes, high cholesterol, a family or personal history of heart or vascular disease and being overweight.

Signs that you may already have PVD include leg cramps when you walk that go away when you rest, cold feet and ulcers or sores on your feet that are slow to heal.

To schedule an appointment at a hospital offering free “Legs for Life” screening this week for peripheral vascular disease, check the web under www.legsforlife.org. (Local libraries can help if you don’t have access to a computer.) For a brochure on the program, call 1-877-357-2847 begin_of_the_skype_highlighting              1-877-357-2847      end_of_the_skype_highlighting.

Eight medical centers in Massachusetts are participating in the screening, including three in the Boston area: Beth Israel Deaconess Medical Center (617-667-8194 begin_of_the_skype_highlighting              617-667-8194      end_of_the_skype_highlighting), Newton-Wellesley Hospital (617-243-6800 begin_of_the_skype_highlighting              617-243-6800      end_of_the_skype_highlighting), and North Shore Hospital in Salem (978-741-1215 begin_of_the_skype_highlighting              978-741-1215      end_of_the_skype_highlighting).

The screening is sponsored by the Society of Cardiovascular & Interventional Radiology and supported by the American College of Foot and Ankle Surgeons, the American Radiological Nurses Association and the Society for Vascular Nursing.

Spit’s new image: a tool for diagnosing disease

September 6, 1999 by Judy Foreman

Among ancient peoples, it is said, this precious bodily fluid was used as the basis of a primitive lie detector test. The accused would be given a handful of rice and told to swallow it; if he couldn’t, it meant he was nervous – and guilty.

This slippery stuff also helps moisten and digest food, and has healing powers as well – proteins that fight bacteria, fungi and viruses and others that speed tissue healing, says Dr. Irwin Mandel, professor emeritus at Columbia University. In fact, animals that lick their wounds heal faster than those who don’t.

The fluid in question, of course, is saliva, or actually, spit – a combination of the saliva pumped out by salivary glands and all the other effluvia floating around in our drool: drugs (licit and otherwise), bugs (viruses, fungi, bacteria), hormones, antibodies and anything else small enough to seep out through tiny blood vessels into the mouth.

As unpleasant as it all sounds, spit is in. In fact, it could be the diagnostic fluid of the future, according to scientists who plan to gather next week at the National Institute of Dental and Craniofacial Research to explore spit’s many wonders – and economic potential.

Already, a number of companies are using the Internet to tout spit test kits, some of which have not been approved by the US Food and Drug Administration, which acknowledged last week it’s scrambling to keep up.

With the kits, consumers muster a little spittle, fork over $60 or so and send the sample to a lab to find out whether, say, their testosterone is tanking, their estrogen slipping, or their stress hormones soaring.

Spit, or more elegantly, oral fluid, is almost identical to the clear part of blood, but with everything – including infectious organisms – present in weaker concentrations. In the past, diagnostic tests were not sensitive enough to detect these low concentrations, but now they are.

That means that almost anything that can be detected in blood can theoretically be found in spit, too – with less pain, risk of infection and expense.

Spit testing is cheap because it’s so safe – neither patient nor health care worker can get stuck with a needle. “You don’t need a technician to get the sample,” says Dr. Stephen Sonis , chief of oral medicine at Boston’s Brigham and Women’s Hospital.

So far, spit tests have only been FDA-approved for a few limited uses – to detect the AIDS virus, illegal drugs, alcohol, a hormone that signals premature labor, and periodontal disease. There are no tests that allow a person to both collect and analyze spit at home – yet.

With the OraSure kit made by the Epitope Corporation of Beaverton, Ore., for instance, you have to go to a health care professional, who puts a toothbrush-like swab between your cheek and gums for a few minutes, then sends the sample to a lab to be tested for HIV. Insurers also use the OraSure kit to test for marijuana, cocaine, opiates or methamphetamines.

In other countries, the kit is used to collect spit for testing for hepatitis B and other diseases. And soon, this kit and others like it could be used to get DNA for testing from prisoners on parole or people at risk for genetic diseases. (It’s unlikely, by the way, that spit samples could be collected surreptitiously from, say, a coffee cup or eating utensil, because the sample would be too small and would degrade quickly without preservation.)

But as spit collecting and preservation techniques evolve, do-it-yourself spit tests could be commonplace.

Already, doctors use spit tests to monitor hormonal changes in infertile women, says Dr. Philip Fox, former clinical director at the National Institute of Dental and Craniofacial Research at NIH and now research and development director at Amarillo Biosciences Inc., in Amarillo, Tex.

Similarly, SalEst , made by Biex, Inc. in Dublin, Ca. allows women at risk of premature labor to have their spit tested by a doctor for the hormone estriol. If estriol rises before 36 weeks of pregnancy, it’s a signal the woman may go into labor prematurely.

But it is the gray area of spit testing through companies on the Web that concerns the FDA, which worries about consumers putting their trust in diagnostic tests that have not been approved.

The Great Smokies Diagnostic Laboratory in Ashville, N.C., for instance, offers spit tests for a number of hormones through its website (www.bodybalance.com). You pick the test – StressCheck, MaleCheck or FemaleCheck – pay $60 and send in your sample to see if your hormones are in the normal range. No doctors are involved.

The company claims the tests are “screening” tools, not true diagnostic tests, and admits its tests are not approved by the FDA. After inquiries from the Globe, the FDA said it is “concerned about the Great Smokies advertising and promotion as well as about other firms that advertise and promote lab tests on the web.”

While it is not illegal for labs to set up an in-house testing service and offer it through health care professionals, it is illegal is to offer this service directly to consumers, says Dr. Steven Gutman , director of the FDA’s division of clinical laboratory devices.

But “the beauty of the test” for consumers, argues Dr. Alison Levitt, a physician at Great Smokies, is precisely that “you don’t need to go to the doctor. . .People are interested in their hormone levels. People want numbers.”

Aeron LifeCycles Clinical Laboratory in San Leandro, California used to offer spit tests directly to consumers, too.

But last year, after federal and state regulators reviewed the lab’s practices, the company decided to put doctors in the loop, though you still don’t need to actually talk to a doctor to be tested, notes George Romero, customer service manager.

You simply send in your spit and $44, pick a name off a company-supplied list of doctors and that doctor signs the test order. For an additional fee, that doctor will help interpret the results, which you also get sent directly.

But how useful is it to send off some spit and get a few numbers that you try to interpret? Probably not very – in part because some hormone levels fluctuate wildly.

To test for stress, for instance, the Great Smokies lab checks levels of two hormones, DHEA (dehydroepiandrosterone) and cortisol. But cortisol levels vary over a 24-hour cycle, so if you send in only two samples a day, as the company website suggests, the potential for misinterpretation would appear to be high. In the version of the stress test sold to doctors, hormones are measured four times a day, says Great Smokies physician Levitt.

For researchers, however, it is precisely this variability in hormone levels that makes spit-tests a gold mine because they can track physiological changes almost in real time.

“When cortisol goes up in the blood, we find it in saliva within 20 minutes,” says Douglas Granger, a Pennsylvania State University behavioral endocrinologist. In studies of people before and after roller coaster rides, cortisol in saliva shoots up within 15 minutes, then returns to normal in an hour.

In other work, Granger has found similar cortisol spikes in kids experiencing family stress.

In one test, he asked mothers and kids to discuss a topic about which they disagreed, then had the kids spit into little cups. The kids judged the most anxious by other tests showed the highest rises in cortisol levels, says Granger, who has formed a research company to study spit for a number of hormones..

Ultimately, with more sophisticated spit kits, consumers could test their oral fluids at home. What spit testing offers, says, Dr. Irwin Mandel, affectionately known among researchers as “the grandfather of spit,” is “a lick and a promise” – a simple, reliable way of monitoring health.

Take care in getting tested

If you decide to have your oral fluids tested, especially by one of the services offered on line, be wary:

  • When collecting the spit sample, follow package directions carefully. Typically, spit samples must be preserved quickly to remain useful. (For instance, if you’ve just eaten or drunk something, rinse your mouth and wait a few minutes before collecting spit.)
  • Think about potential confidentiality problems. Anytime you reveal medical information on the Internet or send bodily fluids through the mail, your confidentiality may be at risk.
  • Remember that a number of medical treatments and conditions, including drugs, radiation therapy, autoimmune problems such as Sjogren’s syndrome, can affect saliva. This could influence the accuracy of your tests.
  • Most important, if you bypass a doctor and use the Internet to find a spit test service on your own, you could be jeopardizing your health. If you’re sick – or worried that you might be – call a doctor.

Odd remedy said to slow deadly cancer

August 9, 1999 by Judy Foreman

Four years ago, Betty Frizzell, a retired schoolteacher from Cookeville, Tenn., was diagnosed with pancreatic cancer, one of the deadliest malignancies there is.

Normally, people with advanced tumors, like Frizzell’s, live only about five months after they are diagnosed. Frizzell, now 64, is thriving on a diet of fruits and vegetables plus a regimen of dietary supplements including pancreatic enzymes and – believe it or not – coffee enemas.She does get a bit tired of carrot juice, she says, and the coffee enemas – two in the morning, two at night – are “very time consuming.” But she’s convinced it’s worth it: “I’m sure I wouldn’t be alive today if I had not chosen this route.”

“Pancreatic cancer strikes almost as many people as leukemia, yet so far, less progress has been made,” says Dr. Robert Mayer , director of the center for gastrointestinal cancer at the Dana-Farber Cancer Institute in Boston.

In fact, pancreatic cancer is so tough to detect that by the time it is discovered, survival is often counted in weeks: 36 to 40 weeks if the cancer hasn’t spread to nearby organs, 16 to 20 weeks if it has. This year, 28,600 Americans will be diagnosed with the disease and 28,600 will die of it, according to the American Cancer Society.

That’s why the mere hint of good news, even from a tiny study of a wacky-sounding therapy involving mega-doses of dietary supplements and coffee enemas, is making the mainstream medical establishment sit up and take notice.

In the July issue of the journal Nutrition and Cancer, a pair of New York private practitioners, Drs. Nicholas Gonzalez and Linda Lee Isaacs, reported their findings on a preliminary study of 11 patients, including Frizzell, with inoperable pancreatic cancer. In all 11, pancreatic cancer was confirmed by a biopsy.

The patients, who followed a dietary regimen at home developed by Gonzalez and Isaacs, lived a median of 17 months after diagnosis, nearly triple the usual survival rate.

The regimen included mega-doses of vitamins and minerals plus pancreatic digestive enzymes such as trypsin and chymotrypsin.

Patients ate no red meat or poultry, had fish several times a week, plus eggs and whole grains. And twice a day, they gave themselves coffee enemas (admittedly bizarre, especially given the fact that a decade ago coffee was thought to possibly cause pancreatic cancer; it has since been shown not to.)

Gonzales suspects that caffeine taken rectally may relax muscles of the liver and gallbladder ducts, causing “toxins,” including byproducts from the body’s attempts to destroy cancer cells, to spill into the intestines. Drinking coffee doesn’t have the same effect, he says. (For what it’s worth, he adds, decaf doesn’t, either; what appears to work is one tablespoon of ground coffee, brewed or percolated, per pint of water.)

Odd as the regimen sounds, it “certainly warrants further investigation,” says Dr. Jeffrey White, who heads the office of cancer complementary and alternative medicine at the National Cancer Institute. In fact, his office recently decided to give $1.4 million over five years to researchers at Columbia University College of Physicians and Surgeons to test the regimen.

Even the director of the new study, Dr. John Chabot, vice chair of the department of surgery at Columbia, doesn’t have the faintest idea why the Gonzalez-Isaacs regimen might work.

“Frankly, when I first read” about it, “I said, ‘That can’t possibly work.’ Then I read the pilot data. . .[ and] said, ‘There really might be something there. I had to come to grips with it myself. I have no idea how or why it might work, but the data are compelling enough that I can’t ignore it.”

In fact, he adds, “it doesn’t matter what the underlying theory is about why it works because I think that’s something for us to investigate once we demonstrate that it works.”

 If it does. The pilot findings could be due to “selection bias,” notes Dr. Karen Antman, who heads Columbia’s cancer center. The people who were able to find Gonzalez and Isaacs and to follow the strict regimen may, for instance, have been more highly motivated or healthier than other patients.

And she can’t imagine why coffee enemas would help: “I don’t get it.” But the mere fact that some patients are alive after three years when they “should have had a median survival of four to six months” means doctors should test the regimen, not just argue with advocates of alternative therapies, she says.

Barrie Cassileth, chief of integrative medicine at Memorial Sloan-Kettering Cancer Center in New York, agrees. Variations on the Gonzalez-Isaacs regimen have been around for decades and have been “something everyone has scoffed at, including me,” she says.

What’s new is that Gonzalez “is going about the situation very systematically, trying to collect research data. That is impressive. . .I support him 100 percent and I will continue to let patients know about this study” at Columbia, she says.

She wishes the coffee enema part could be dropped because “that’s what makes people laugh at it.”

But the researchers say that, to be valid, the new study has to replicate the whole regimen because nobody knows which parts, if any, may help.

Gonzalez concedes that he, too, was initially taken aback by the idea of coffee enemas. “When I first heard about coffee enemas, I thought that was the single weirdest thing I ever heard of,” he says.

Until 20 years ago or so, the coffee enema was actually listed in the Merck Manual as a general treatment to help people feel better, though not for any particular disease. Since then, it has gained some notoriety, mostly as a new-age remedy for depression and other ailments; coffee enemas have been widely publicized on the Internet and by Hollywood stars such as Janet Jackson.

Michael Lerner, president of Commonweal, a health and environmental research institute in Bolinas, California, has researched what scientific literature there is on coffee enemas and, while not an advocate, notes that they were part of a cancer treatment developed decades ago by Dr. Max B. Gerson, a German physician. But solid data on efficacy is scarce, Lerner says.

Cassileth of Sloan-Kettering agrees, noting that repeated enemas could weaken colon function, triggering constipation. Coffee enemas could also remove potassium from the body and trigger potentially fatal electrolyte imbalances, as well as dehydration, she says, though Gonzalez says this is unlikely.

As for the pancreatic enzymes, Gonzales thinks they may have a direct anti-cancer effect, though this is unproved.

The design of the new study is simple. Columbia researchers are seeking a relatively small group of people – 72 to 90 patients – with pancreatic cancer at Stages II, III or IV, that is, cancer that is confirmed by biopsy to have spread beyond the pancreas.

Half the patients will then be randomly assigned to get the dietary regimen through Gonzalez and Isaacs and half to a chemotherapy drug, gemcitabine, which improves quality of life but prolongs it only slightly.

About 30 patients have been interviewed, but all want the dietary regimen, not gemcitabine. There’s another problem, too. Ideally, says Mayer of Dana-Farber, the researchers should not lump together three stages of cancer. If one group lives longer but has more people with less advanced cancer, it will be impossible to know whether the treatment was better or the patients were simply less sick.

Meanwhile, Betty Frizzell just keeps growing organic veggies in her garden, making her own bread and cooking Sunday dinner every week for 14 people. (Then she prepares her own meal.)

Her big problem now is that the government “is fixing to build a big interstate highway” on half of her 90-acre farm. She fears “it will be harder to fight the federal government than pancreatic cancer.”

More on pancreatic cancer

To find out about joining the new pancreatic cancer study, call Dr. John Chabot at Columbia University, 212-305-9468 begin_of_the_skype_highlighting              212-305-9468      end_of_the_skype_highlighting .

You can also read about the trial of nutritional therapy on the Web. Go to the National Cancer Institute’s Web site at http://wwwicic.nci.nih.gov/ and then click on PDQ, clinical trials database, PDQ clinical trials user’s guide, then PDQ clinical trials search form. Under diagnosis, click on “pancreatic cancer, exocrine.” The study is number 24 on the list.

To learn more about alternative cancer therapies in general, take a look at:

  • “The Alternative Medicine Handbook,” by Barrie R. Cassileth, published by W.W. Norton & Co.
  • “Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer,” published by the MIT Press.

FETAL SURGERY — MIRACLE BEFORE BIRTH — PROCEDURES DONE IN THE WOMB BOTH AMAZE AND RAISE MANY QUESTIONS

August 2, 1999 by Judy Foreman

A SPECIAL REPORT

Etched in the memories of Dennis and Melinda Stover is the day they learned their baby would be born with spina bifida.

It was January, and Melinda, a 26-year-old-bank teller from Murfreesboro, Tenn., was 20 weeks pregnant. She was having an ultrasound exam because they already had two girls “and if it were a boy, we had a lot of stuff to buy,” said Dennis, a 31-year old surgeon’s assistant. No matter what the exam might show, abortion was unthinkable: “We’re born-again Christians.”

What it did show was that their fetus had spina bifida, a defect in which the spinal canal fails to close around the spinal cord. (Spina bifida affects 1 in 2,000 newborns and can often be prevented by taking folic acid — found in multivitamins and some fruits and cereals — from the onset of pregancy.)

Many children with spina bifida have such severe neurological damage that they need braces to walk and have problems with bladder and bowel function. Most also develop hydrocephalus, or excess fluid in the brain, which requires repeated operations to implant shunts to drain fluid into the abdomen.

Beyond the enormous human cost, the economic cost of caring for such a child is “astronomical,” notes Dr. Arnold Cohen, a former perinatologist who is now corporate medical director for women’s health at Aetna US Healthcare in Blue Bell, Pa.

So the Stovers decided to take an unusual chance. They live just half an hour from Vanderbilt University Medical Center in Nashville, where over the last two years Dr. Joseph P. Bruner, director of fetal diagnosis and therapy, has done 53 experimental operations on fetuses to correct spina bifida.

This kind of dramatic surgery is so new and requires such specialized surgical teams it is done only at Vanderbilt and two other centers — Children’s Hospital of Philadelphia and the University of California at San Francisco — though others are gearing up to do it. It also raises a number of medical, ethical, and insurance issues, partly because there are no long-term data.

The operation Melinda Stover had at 23 weeks of pregnancy is conceptually simple. Through a Caesarean section, the uterus is pulled up and placed on the woman’s abdomen. A tiny incision is made in the uterus, so the amniotic fluid that bathes the fetus can be withdrawn through a needle and stored in the operating room to be put back later.

The uterus is then cut open and the fetus exposed so doctors can close the gap over the spinal cord. By closing the gap before birth, doctors reason, the spinal cord can be protected from physical trauma as the fetus bumps around in the uterus and from toxic compounds in the amniotic fluid. Closing the gap before birth also appears to reduce the risk of hydrocephalus.

Although the Stovers’ daughter, Meghan, was born with club feet and no muscle function below her knees, her bowel and urinary functions are intact and the family has no regrets about the surgery. In fact, they’re “thrilled to death” with Meghan, who was born in April. “We could not be happier,” Dennis Stover says.

Cohen of Aetna calls this type of surgery nothing short of “miraculous.” While many insurers — including the Stovers’ — balk, Cohen was so awestruck after watching an operation, he convinced Aetna to contract with Vanderbilt to pay for patients to have the procedure, which costs about $35,000.

“It intuitively makes sense” as a way of reducing the need for repeat operations and expensive long-term care, he said.

Though a few doctors experimented with fetal surgery in the 1960s, it was not until the early 1980s that, after numerous experiments in animals, Dr. Michael Harrison, director of the fetal treatment center at UCSF, began operating on fetuses with life-threatening tumors that inhibit lung growth and others that grow at the base of the spine, sapping the fetus’ blood supply.

Back then, “it only seemed justifiable” to attempt fetal surgery for such potentially fatal problems, says Dr. N. Scott Adzick, director of the center for fetal diagnosis and treatment at Children’s Hospital of Philadelphia.

In fact, nobody would have considered exposing the mother and fetus to the rigors of surgery for a non-fatal problem like spina bifida for the very reason that the gap over the spinal cord can be closed and a shunt can be implanted to treat hydrocephalus after birth.

And the risks of fetal surgery to both mother and fetus are considerable, including the chance that in the weeks afterwards, the uterus can contract so much the baby will be premature or even stillborn. To prevent this, mothers are now given drugs such as magnesium and terbutaline until it’s time — at about 34 weeks of pregnancy — to deliver the baby by another C-section.

(C-sections are necessary because fetal surgery creates a fresh uterine wound; with vigorous contractions during labor, that wound could rip, jeopardizing both mother and fetus.)

By the mid-1990s, Bruner decided it was time to try fetal surgery on fetuses with non-lethal malformations. He operated on four fetuses with spina bifida.

“It was an unmitigated disaster,” he says. His team worked endoscopically — not through a big incision in the woman’s abdomen as he does now, but through tiny incisions through which instruments and a TV camera were inserted. Although surgeons now use endoscopic fetal surgery for other malformations, Bruner’s tiny spina bifida patients did not fare well with this approach; two died and two were born prematurely.

So Bruner switched to the open procedure, and the results, he says, are encouraging, though he concedes it’s not yet clear whether the surgery increases the chance that a child with spina bifida will walk.

But while most babies born with spina bifida eventually need shunts for hydrocephalus, only half of those who get the fetal surgery do, perhaps because, by repairing the spinal lesion, fluid does not build up as much in the brain.

The Vanderbilt team was so eager — many say over-eager — to spread the word, it put its findings on the Internet in mid-1997 and later helped publicize them in the magazine Woman’s Day and on Dateline NBC. The study results were then submitted to the New England Journal of Medicine, but the journal declined to publish them. (The data remain unpublished, but have been submitted to another journal.)

Dr. Michael Greene , director of maternal and fetal medicine at Massachusetts General Hospital and the editor who reviewed the paper, says Bruner’s paper was rejected because it dealt only with the first 10 or so successful cases and made no mention of subsequent ones, where the operation “went sour.”

Bruner’s enthusiastic self-promotion also irked his rivals, especially Adzick of Philadelphia, who notes that his team has performed about half of the 250 to 300 open fetal surgeries done worldwide and whose own work on one case was published in Lancet, a British medical journal. (Both men say they’ve now patched things up and refer patients to each other.)

And while, understandably, some parents of children with spina bifida complain on Vanderbilt’s website that the surgery was not available to help them, those who have had it are immensely grateful.

Patricia Switzer, 34, a computer scientist, and her husband, Michael, 35, an Army test pilot stationed at Fort Rucker, Ala., discovered when she was 21 weeks pregnant that their fetus had spina bifida. She had the surgery three weeks later.

Though they’re still fighting with their insurer to pay for the procedure — and the $300-a-day drugs she needs to prevent premature delivery — the Switzers are glad they took the risks. “I would do anything for my baby,” Patricia says.

As for the Stovers, their insurer did not cover the surgery, but their church raised $11,000 for them, and they’d do it all again if they had to.

“We aren’t striving for a perfect baby,” Dennis Stover says. “We just want to do what’s best. . .I feel we are pioneers, but someone has to be. Someone has to say, `I am willing to do this not just for my baby, but for the rest of babies.’

Judy Foreman is a member of the Globe staff. Her e-mail address is: foreman(AT SIGN SYMBOL)globe.com.

Previous “Health Sense” columns are available through the Globe Online searchable archives athttp://www.boston.com. Use the keyword columnists and then click on Judy Foreman’s name.

SIDEBAR:

‘Closed’ procedures are the future

Although “open” fetal surgery is dramatic, doctors are increasingly turning toward “closed” or minimally invasive procedures in which thin instruments and a small TV camera are inserted through tiny incisions; sometimes they use ultrasound to guide needles to insert shunts.

At New England Medical Center, Wendy Andrasy, 33, a Weymouth police officer, has already reaped the benefits of this approach.

When she was pregnant two and a half years ago, her fetus had an enlarged bladder, a sign that something was obstructing the flow of fetal urine into the amniotic fluid. This can cause kidney damage as urine backs up; it can also sabotage lung development.

Fetal urine contains a growth factor that is “essential for lung development,” says Dr. Diana Bianchi, chief of genetics at the Floating Hospital for Children at New England Medical Center. Normally, the fetus “is inhaling its urine and that is allowing this growth factor to get to the lungs.”

But Andrasy’s fetus wasn’t getting that growth factor. So when she was 20 weeks pregnant, Dr. Sabrina Craigo, a perinatologist at NEMC, slipped a tube through Andrasy’s uterus, using ultrasound guidance, and placed a drainage shunt with one end in the fetal bladder and the other in the amniotic sac.

At the University of California in San Francisco, Dr. Michael Harrison, director of the fetal treatment center and the undisputed leader in fetal surgery, is pushing the envelope even further.

Harrison notes that 1 in 2,000 babies is born with a diaphragmatic hernia, a hole in the diaphragm that allows the intestines and sometimes the liver to poke up into the chest cavity. When this happens, the lungs get so compressed they never develop, which means that as soon as the baby is born, it dies.

The solution is counterintuitive: occlude the fetal windpipe. Fetal lungs make fluid that pours into the airway and out of the mouth; by blocking this outflow, the fluid, which spurs lung growth, is pumped back into the lungs.

Harrison’s team has perfected a way to close the fetal windpipe endoscopically with a clip that is placed on the fetal trachea during surgery and left there for the remainder of the pregnancy. It is then removed during delivery by C-section so the baby can breathe normally. The results on the first dozen patients, not yet published, suggest that it works much of the time, he says. At Children’s Hospital in Boston, Dr. Rusty Jennings , director of fetal diagnosis and treatment, is gearing up to do the trachea procedure, as well surgery for spina bifida and other problems.

At a number of hospitals nationwide, including New England Medical Center and Hasbro Children’s Hospital in Providence, doctors are working on ways to use endoscopes and lasers to treat yet another fetal abnormality, the mixing of blood between identical twins whose blood vessels join in the placenta. When this happens, says Dr. Francois Luks, associate professor of surgery and pediatrics at Brown University, one twin’s heart tries to pump blood for both, causing heart failure; the other twin often dies from anemia because it gets too little blood.

As for Andrasy, her son was born two years ago. The surgery prevented the child’s death from underdeveloped lungs, but was not able to prevent kidney damage — in fact, he needs a kidney transplant. But Andrasy, now pregnant again, was thrilled: “He’s wonderful. They saved his life. He’s funny. He’s a great kid. He smiles all the time.”

Rotator cuff is a tough but fragile thing

July 26, 1999 by Judy Foreman

Problems with the shoulder, the second most unruly joint in the body after the knee, send 4 million Americans to their doctors each year.

With young people – and active older folks as well – it’s usually a sports injury. But aging, along with plain old wear-and-tear, also wreak havoc on this flexible yet delicate joint.

“The shoulder is the most mobile joint in the body, but it’s the most unstable, too. What we gain in motion, we lose in stability,” says Dr. Jeffrey L. Zilberfarb, a shoulder surgeon at Beth Israel Deaconess Medical Center in Boston.

Indeed, the shoulder is the only place where tendons pass through a tight space between bones, making it a “set-up” for trouble, says Dr. Michael Wirth, an orthopedic surgeon at the University of Texas Southwest Medical Center in San Antonio.

And trouble comes in various forms. Tendons and muscles can shred as a result of wear and tear, making arm movement agonizing or impossible. Ligaments can be so loose congenitally or become that way from trauma or over-stretching that the arm slips out of the socket, a problem called instability or dislocation, depending on the severity. The opposite can happen, too – a shoulder joint can become so stiff from scar tissue that it becomes “frozen.”

Two summers ago, Carol Furneaux, a 55-year-old musical conductor from Carlisle, tripped over her 100-pound black lab as she got out of bed one night. The dog barely noticed.

But as she landed on her outstretched right arm, she felt a searing pain through her shoulder. By morning, the acute pain had subsided, but she couldn’t lift her arm.

Dr. Alan Curtis , an orthopedic surgeon at New England Baptist Hospital, gave her the diagnosis: a torn rotator cuff, the group of muscles and tendons that stabilizes the shoulder. He stitched it up surgically through a tiny incision and Furneaux was fine.

Until last summer, that is. She’d just had knee surgery (it has not been a good couple of years, she says) and was dutifully soaking her leg in a Jacuzzi. But as she hoisted herself out with her arms, she ripped her other rotator cuff. The verdict: another surgery.

Shoulders are particularly vulnerable to problems because a lot can go wrong in a relatively compact area. For one, spurs, or small protrusions, can develop on the acromion, a bone that sits on top of muscles and tendons, which connect the muscles to bone. The spurs rub against soft tissue, resulting in irritation and pain.

“Every time you reach forward, if the acromion has spurs on it, it rubs on top of the cuff, causing impingement, ” notes Curtis of the Baptist.

Sometimes, impingement of soft tissue is simply the result of poor anatomy – the acromion angles too far down. In other cases, the space is cramped because the bursa, a sac of fluid that lubricates the shoulder, becomes inflamed. Impingement can also occur if the rotator cuff muscles are weaker than the deltoid muscles in the arm – when the arm is raised, the cuff gets pinched.

Impingement often leads to tendonitis, an inflammation of the tendons. For reasons that are unclear, tendonitis may also cause calcium deposits in the cuff, which further irritates tissues, causing acute pain.

In 95 percent of cases, tendonitis gets better with simple remedies like rest, ice, and anti-inflammatory drugs. In severe cases, an injection of cortisone into the space beneath the acromion may be needed.

But with enough wear and tear – or with a sudden, acute injury like Furneaux’s – shoulder muscles and tendons can literally tear away from the bone. Tears that only go partway through the thickness of the rotator cuff often heal without surgery, says Curtis. But tears that go all the way through or that cause persistent pain or weakness demand surgery.

Historically, this meant a four- or five-inch incision to peel the deltoid off the acromion to gain access to the rotator cuff and stitch up the tear. The deltoid is then reattached and must heal, which takes six weeks or more. If the deltoid fails to re-attach properly after surgery, it can be irreparable.

“The worst case scenario,” says Curtis, “is a failed cuff repair and a failed deltoid repair. Then you have no cuff, no deltoid. You lose the ability to raise your arm, and there’s no good answer for that.”

In recent years, doctors have increasingly turned to less invasive, arthroscopic surgery. This involves making three quarter-inch incisions through which tiny cameras and instruments are inserted to enable doctors to sew up small tears as they monitor the procedure on a screen. For medium-size tears, doctors use a “mini-open” surgical technique, in which the deltoid is split, but not detached from the bone.

Although athrosocopy makes for speedier healing – it’s day surgery versus a night or two in the hospital for the larger incision – it’s still technically difficult enough that many surgeons haven’t yet learned to do it.

Meanwhile, surgeons are turning to a growing number of high-tech approaches for other shoulder problems.

Robert Colman is a 32-year-old Brookline man who works as a “grip,” or TV and film lighting specialist. That means he’s constantly lifting and holding lights over his head. Gradually, he says, pain from his shoulder instability became intolerable.

But instead of repairing Colman’s overstretched ligaments the old way – removing pieces of the ligaments and sewing the ends together through an open incision – his surgeon, Zilberfarb, repaired it with a new technique called thermal capsular shift.

This involves inserting lasers or radiofrequency probes through tiny incisions and heating ligaments to 152.6 degrees Fahrenheit, under anesthesia. The heat shrinks the collagen in ligaments, which causes scar tissue, which in turn tightens up the ligaments.

Potentially, ligaments could stiffen up too much or stretch out again over time. So far, though, Colman’s had no problems – he’s lifting weights and says he’s “glad I had the surgery.”

Many surgeons also now shave bone spurs off the acromion (a procedure called acromioplasty or subacromial decompression) during an arthoscopic procedure. This widens the space between the acromion and the soft tissues.

Wirth and others are also testing new ways to strengthen shoulder tendons with grafts of a material called SIS (made from the lining of the small intestine in pigs).

“It’s remarkable stuff,” he says. The material, which triggers the re-growth of tendons that have become too thin, is only done experimentally at this point.

As for “frozen” shoulders, the solution is more low-tech: stretching and physical therapy. It can take a year or more to “thaw” a frozen shoulder, with exercises to increase range of motion and break up scar tissue. In really stubborn cases, it may take surgery to remove excess scar tissue.

Many people simply live with their shoulder problems, hoping they’ll go away. And often they do. But others – especially men and older people – tend to wait too long to seek help, giving up one activity after another and putting up with considerable pain.

“What brings many men into the office is wives who can’t sleep because their husbands toss and turn because of shoulder pain,” Zilberfarb says. “Guys are in denial. We’d wait until an arm falls off to come in.”

Older people, too, often wait until the torn cuff atrophies and retracts into the socket.So the moral, as Furneaux puts it, is simple: “Don’t put it off.” With her first shoulder injury, she waited almost six months to see a doctor. “I was almost at the point where they couldn’t repair it,” she says.

Now, thanks to two athroscopic surgeries, she says, “I can lift both my arms over my head. It’s like it never happened.”

Divining and treating shoulder problems

The rotator cuff is a group of four muscles and tendons that hold the shoulder together and give it strength and flexibility. Together, these tissues hold the upper arm bone (humerus) in the shoulder socket (glenoid).

Problems can be diagnosed by X-rays (including an arthrogram, in which dye is injected into the shoulder to highlight the rotator cuff) and tests like CT scans, EMGs (electromyelograms, which assess the ability of nerves to stimulate muscle contractions), MRIs, and ultrasound, says Dr. Jeffrey L. Zilberfarb, an orthopedic surgeon at Beth Israel Deaconess Medical Center in Boston.

But you may be able to figure things out more simply. Sit on a chair with your arm held horizontally in front of you, elbow bent. Have a doctor or a friend push down lightly on the top of your hand as you pretend to pour water out of a glass. If it hurts as you “pour,” your rotator cuff may be irritated and you should see a doctor, says Zilberfarb.

Most shoulder problems can be treated without surgery. Try the following:

  • Rest. In bed, lie on your good side and put a pillow between your injured arm and your side to take the pressure off the shoulder. When you’re not in bed, if your shoulder is very painful, keep your arm in a sling for a few days. (But if you have a fever, get to an emergency room – you may have a “septic shoulder,” a serious infection.) Never rest so much that your shoulder gets stiff – alternate rest with gentle exercise. – Cold. If you have tendonitis, put ice on your shoulder for 20 minutes 3 times a day. Cold helps by reducing inflammation.
  • Heat. If your shoulder is stiff, try heating pads and gentle exercises like standing in a hot shower with your shoulder against a wall and “walking” your fingers up the wall. Heat helps by increasing blood flow to injuried tissues.
  • Medications. Over the counter anti-inflammatory drugs like ibuprofen often help. For severe cases, you may need cortisone injections or cortisone cream applied to the skin.
  • Ultrasound. Like heat, ultrasound waves can warm tissues in the shoulder, improving blood flow and speeding the healing process.
  • Electrical stimulation. TENS, or transcutaneous electrical nerve stimulation, can ease pain by sending electrical signals through the skin to your shoulder to block pain signals.
  • Exercises – done gently – can also help heal injured shoulders and prevent further injury. Here are some:
  1. Take a towel and drape it over your good shoulder. Hold the front end with your good hand. Put your bad arm behind your back and grab the dangling end of the towel. Pull gently with your good arm to raise your injured arm. Hold for a few seconds then repeat five to 10 times.
  2. Rest the hand of your bad arm on the shoulder of your good arm. Take your free hand and pull the elbow of your bad arm toward your good side to stretch your bad shoulder. Hold the stretch for 10 seconds, then repeat. You can also do this lying down.
  3. Take an inner tube from a bicycle tire or color-coded rubber tubing from a physical therapist. Tie it to a doorknob. Stand with your injured shoulder toward the doorknob. With your bad elbow pressed against your side, hold the end of the band and pull it toward your good side. Repeat 10 times. Then turn so that your good shoulder is toward the doorknob. Grab the tubing with your bad arm, and move it away from your body, again keeping your elbow tucked in.

Picturing heart disease another way

July 19, 1999 by Judy Foreman

Richard Knorr’s heart is making medical history.

But there’s actually not much that’s unusual about it. Though two of his coronary arteries are partially blocked, the 64-year-old Framingham man has never had a heart attack and he can control his chest pain with medications.

Still, doctors are fascinated by his heart, and those of a handful of other coronary patients at Beth Israel Deaconess Medical Center in Boston, because they’ve found what seems to be a safe, painless, noninvasive way to detect heart blockages.

If the researchers, led by Dr. Warren J. Manning, co-director of the hospital’s Cardiac MRA Center, are right, the imaging technique – called 3-D coronary magnetic resonance angiography – could someday replace standard angiography. In this invasive procedure, doctors thread a catheter through an artery in the groin up to the heart, inject iodine dye through the catheter, and then view X-ray images of the arteries on a monitor, enabling them to see blockages.

Magnetic resonance imaging has actually been in use for about 10 years to scan blood vessels, but it’s mainly used in parts of the body, such as the brain, that don’t move. Imaging the heart and coronary vessels has proved tougher because of the blurring that’s caused by each heartbeat and respiration.

Indeed, imaging coronary vessels is “the holy grail of MR angiography,” says Dr. William Palmer, clinical director of magnetic resonance imaging at Massachusetts General Hospital.

If an international study now underway confirms Manning’s preliminary findings, which were published recently in the journal Circulation, the technique could be available in a couple of years, Manning says, though others think that’s too optimistic.

It’s also possible that the technique will not be able to match the 90 percent accuracy of standard angiography, warns Dr. Robert Herfkens, director of Magnetic Resonance Imaging at Stanford University.

Like 1.7 million other Americans who will have a coronary angiogram this year, Knorr can vouch for the fact that the current tests are no fun. The first time was “very, very intimidating,” says Knorr, who has had it done twice.

Most serious is the risk of heart attack, stroke or death, which occurs less than 1 percent of the time, says Dr. Peter Danias, a Beth Israel cardiologist and co-author on Manning’s paper. But there’s also risk of artery damage and bleeding from the incision where the catheter is inserted. To minimize bleeding, patients must lie still for four to six hours after an angiogram.

On top of that, some patients have allergic reactions to the dye (or “contrast agent”) injected to highlight the image of the arteries. And the radiation from the X-rays needed to “see” the arteries can damage tissue.

No wonder, then, that researchers have been scrambling for safer, noninvasive alternatives.

One hope is improved CT (computerized tomography) scans, though like regular angiograms, CT angiograms involve radiation (taking a series of X-ray slices that a computer stacks into 3-dimensional images) and injections of a contrast agent.

Newer, so-called fast CT scans that take four X-ray slices at once may be particularly useful for cardiac problems because they can be timed to get images of the heart between beats, says Dr. Andre Duerinckx , chief of cardiovascular magnetic resonance imaging at the Greater Los Angeles Health Care System.

Another alternative might be ultrasound, in which sound waves are bounced off the body and reflected back as an image. But sound waves don’t penetrate deeply enough to “see” coronary arteries, so this technique is mainly used to scan superficial vessels like the carotid arteries in the neck or veins in the leg.

In magnetic resonance, or MR, the patient is placed in a strong magnetic field and radio waves are sent into the body. This causes changes in the alignment of protons, or hydrogen atoms, the building blocks of molecules.

When the radio waves are stopped, the protons fall back into alignment with the magnetic field; in doing so, they send out their own radio waves, which are detected and used to create an image. With MR, doctors can track the flow of blood through vessels and the anatomy of the vessels as well, looking for spots where the flow is blocked by clots.

Several years ago, Manning’s team showed that coronary MR angiography could yield images if the patient held his breath repeatedly for 20 seconds or so at a time. Now, partly by tweaking the computer software, Manning’s new research shows it’s possible to get better images, at least in parts of arteries closest to the heart, without patients having to hold their breath.

In a tiny group of patients – Richard Knorr and four others – with known coronary disease, the MR scans corresponded “very well” with results from traditional angiograms, Manning says.

Still, MR imaging of the coronary arteries is “not ready for prime time” and may never be “comparable in quality” to standard angiograms, cautions Palmer of MGH, whose team is also working on the MR techique. In fact, because of the magnetic field, MR is not safe for people with pacemakers and some people with metal clips in their brains to treat aneurysms. MR may be safe for some of those who have metal stents implanted to keep arteries open.

But MR can only diagnose a clogged artery, not treat it. With standard angiography, doctors can not only image arteries but insert stents or use a balloon to compress artery-clogging clots as part of the procedure.

And while standard angiography can detect blockages anywhere in coronary arteries, so far MR works best at spotting problems only near the aorta, the heart’s largest artery.

Although one advantage of MR is that it can be done without a contrast agent, doctors sometimes inject a substance called gadolinium to make blood vessels show up better on scans. A new generation of contrast agents may further improve coronary MR, says Herfkens of Stanford.

But even in its current stage of development, the MR technique already has one enthusiastic fan: Richard Knorr. With each standard angiogram, he had to make two trips to the hospital – one for preliminary blood tests and one for the angiogram itself. With the standard angiogram, he says, “you’re confined all day in an OR,” compared to just an hour or so with magnetic resonance.

And with standard angiograms, he says, “you’re surrounded by three, four, five people getting you ready. . .I don’t want to put them out of a job, but. . ..”

Cancer patients battle fatigue

July 12, 1999 by Judy Foreman

By this time Dr. Candace Jennings, 50, an orthopedic surgeon from Ipswich, figured she’d be back to work and blessed again with plenty of energy for her husband and sons, 7 and 13.

But even though it’s been a year since she finished chemotherapy and radiation for breast cancer, she’s only got half the energy she used to have. She tried to go back to work but had to give it up – “the energy demand was too much,” she says. And her doctors, while sympathetic, haven’t offered much hope.”Somebody’s got to solve cancer fatigue,” she says passionately. “It really affects your self-esteem,” especially if you’re used to being productive. “When you can barely get out of bed to go to the bathroom, it’s very hurtful.”

In recent years, cancer specialists have made huge strides in combatting the nausea, vomiting, and pain that often accompany cancer and its therapy, but treatment for the fatigue that can last long after treatment lags far behind. In fact, it’s a huge, under-recognized, problem for many of the 8 million Americans who’ve had cancer.

Two years ago, an organization called the Fatigue Coalition – a group of doctors, nurses, and advocates funded by Ortho Biotech to study cancer fatigue – surveyed 419 patients and found that fatigue, not pain, was the most common complaint, although half had completed treatment more than a year earlier.

In May, the group presented its latest data at a cancer conference in Atlanta. Again, fatigue was the big complaint, even two years after treatment; 76 percent of the 379 patients queried had debilitating fatigue at least once a week.

That’s “absolutely staggering,” says Dr. Russell Portenoy, head of pain medicine and palliative care at Beth Israel Medical Center in New York and chairman of the coalition.

It’s “inexcusable,” he adds, that so many cancer patients think they must simply accept feeling wiped out, and that doctors don’t take their complaints more seriously.

 But this is beginning to change. The M.D. Anderson Cancer Center in Houston recently opened a special facility to treat cancer fatigue. Memorial Sloan-Kettering Cancer Center in New York is planning one, too, and so is New York’s Beth Israel.

And though the research is preliminary, there are signs that better treatments will become available as scientists begin to untangle the many causes of cancer-related fatigue.

In some cancer patients, perhaps 15 percent, depression and anxiety are likely causes of fatigue, says Dr. William Breitbart, a psychiatrist and internist at Sloan-Kettering. But for many more, it’s the other way around – they get depressed because of their lack of physical energy.

Sometimes, fatigue is caused by the cancer itself as tumors compete with healthy tissue for nutrients. In other cases, it’s the treatments that cause fatigue – chemotherapy and radiation, or even relatively nontoxic immune-boosting drugs.

In fact, the fatigue caused by immune-modifying drugs like the interferons, the interleukins, and tumor necrosis factor is so common and so profound that researchers suspect the natural forms of these substances, called cytokines, which are made as the body tries to fight cancer, are also triggers of fatigue.

In one small study, Dr. Donna Greenberg, a Massachusetts General Hospital psychiatrist, found that a cytokine called IL-1 rose in prostate cancer patients several weeks after radiation, just as fatigue increased, though she cautions that the connection between the two events is still unclear.

Other studies on cytokines and fatigue have had ambiguous results, says Barbara Piper, an associate professor of nursing at the University of Nebraska Medical Center who works with the Oncology Nursing Society to study cancer fatigue. Despite the embryonic understanding of the physiology of fatigue, researchers are finding ways to fight it.

At Sloan-Kettering, Breitbart has just completed a study showing that the psychostimulant drugs, Ritalin and Cylert, when used alone, improved fatigue significantly over a placebo in people with AIDS, which like cancer, can cause exhaustion.

The once-banned drug thalidomide may help, too, he says, perhaps by combatting the fatigue-inducing effects of tumor necrosis factor.

Anecdotal evidence suggests that steroid drugs like dexamethasone or prednisone may also temporarily boost energy in cancer patients, says Beth Israel’s Portenoy. A drug called amantadine, already used to treat fatigue in people with multiple sclerosis, may help, too.

At M.D. Anderson, Dr. Tejpal Grover will study yet another drug, Provigil, recently approved by the US Food and Drug Administration for narcolepsy, a disorder in which patients suffer sudden sleep attacks. No one knows quite how it works, he says, but it seems to have stimulating effects like Ritalin.

When fatigue is due to anemia, which can be caused by the cancer itself or cancer therapy, iron supplements, blood transfusions, or drugs that boost red blood cells such as Procrit, made by Ortho Biotech, often help considerably.

Fatigue has also been linked to low white blood cell counts, which occur when chemotherapy damages the bone marrow. There are drugs that stimulate white-cell growth, but they are usually used to protect against infection, not to boost energy.

In some patients, fatigue lifts when infections and chronic pain are treated. And addressing fairly common problems like an underactive thyroid gland, which could be overlooked in a person with a larger problem like cancer, also helps.

The bottom line, says Dr. Wendy S. Harpham, a doctor in Dallas who, like Candace Jennings, had to give up her practice when cancer struck, is that fatigue is one of the toughest adaptations that many patients have to make.

In some ways, she says, “the adjustment to my energy limitations has been harder than managing many of the other challenges of survivorship.”

Jennings echoes that. Giving up her practice was difficult, she says, though she’s found deep satisfaction as a part-time volunteer high school biology teacher. Exercise helps, too. And so do friends, who boost energy by helping keep her morale up.

A year ago, as she was finishing chemo, her friends took cuttings from their own yards and planted a “recovery garden” in hers. Recently, they got together to celebrate the flourishing garden and Jennings’ courage. Not only could their energy prove contagious, the garden’s may, too. It’s doing so well, she says, “it’s as if it’s imbued with some kind of magic.”

Drug-free ways to fight weariness

In addition to new drug strategies to combat cancer fatigue, researchers are exploring non-drug approaches.

A number of studies have shown that exercise – even gentle walking several times a week – seems to boost energy, says Paula Rieger, a nurse practitioner at the University of Texas MD Anderson Cancer Center and president-elect of the Oncology Nursing Society.

Using energy wisely – saving it for the things you really care about – also helps, says Dr. Donna Greenberg, a Massachusetts General Hospital psychiatrist. “Be thrifty with energy,” she says. Delegate jobs – like grocery shopping – that someone else could do. Go to one social event, not two. If you’re freshest in the morning, do the important things then, and then rest.

And try to avoid self-criticism for feeling tired. “People are harsh on themselves for not being able to fulfill obligations and for needing help,” Greenberg says. “Fatigue is invisible and there’s no lab test for it. That means that people often question whether their fatigue is physical or emotional, and it’s hard to know whether to push yourself or rest.”

Many tired patients also assume that their fatigue is a sign that their cancer is progressing. Often, that’s not true.

Learning to expect fatigue also takes some of the worry out of it, cancer researchers say. Keeping a diary of the ebb and flow of energy can help, too, particularly in helping tease apart the different patterns of fatigue.

If you’re reasonably energetic and motivated in the morning, but then fade, that’s a sign you’re not depressed but simply run out of energy.

If you can hardly get out of bed in the morning and have lost interest in doing normal things, that’s a clue you may be depressed. Depression is highly treatable with anti-depressant medications and psychotherapy.

Disrupted sleep can also lead to fatigue, so sleep “hygiene” – sticking to a regular sleep-wake cycle and avoiding caffeine and other stimulants in the evening – helps.

And diet can help, too. Make sure you’re getting enough calories and that you plan meals that appeal to you.

« Previous Page
Next Page »

Copyright © 2025 Judy Foreman